<!DOCTYPE html SYSTEM "about:legacy-compat">
<html class="no-js">
  <head>
    <meta charset="utf-8"/>
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"/>
    <title>D.C. Law Library - D.C. Act 23-536. Opioid Overdose Treatment and Prevention Omnibus Amendment Act of 2020.</title>
    <meta property="st:title" content="D.C. Act 23-536. Opioid Overdose Treatment and Prevention Omnibus Amendment Act of 2020."/>
    <meta name="description" content="Browse the laws and code of the District of Columbia"/>
    <meta name="viewport" content="width=device-width"/>
    <link href="https://fonts.googleapis.com/css?family=Open+Sans:400italic,700italic,400,700" rel="stylesheet" type="text/css"/>
    <link rel="stylesheet" type="text/css" href="/css/main.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/print.css" media="print"/>
    <script type="text/javascript">
        var _paq = _paq || [];
        _paq.push(['trackPageView']);
        _paq.push(['enableLinkTracking']);
        (function() {
            var u="//analytics.code.dccouncil.us/";
            _paq.push(['setTrackerUrl', u+'piwik.php']);
            _paq.push(['setSiteId', 1]);
            var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
            g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'piwik.js'; s.parentNode.insertBefore(g,s);
        })();
        
        window.searchHost = 'https://search.code.dccouncil.us';
        window.queryUrl = '/v1/search';
    </script>
    <noscript>
      <p>
        <img src="//analytics.code.dccouncil.us/piwik.php?idsite=1" style="border:0;" alt=""/>
      </p>
    </noscript>
  </head>
  <body>
    <header>
      <section class="container">
        <a href="http://dccouncil.us">
          <img src="/css/header_logo.png" alt="DC Seal" class="header_logo"/>
        </a>
        <h1 id="sitename">
          <a href="/dc/council/acts/23-536.html">D.C. Act 23-536. Opioid Overdose Treatment and Prevention Omnibus Amendment Act of 2020.</a>
        </h1>
        <div class="right no-print search" id="search"> </div>
      </section>
    </header>
    <main class="main container">
      <div class="clearfix" style="width: 100%;">
        <aside id="sidebar" class="col3 quiet">
          <h2>You Are Here</h2>
          <ul class="ancestors">
            <li data-search-path="library|D.C. Code" data-search-heading="D.C. Code" data-search-default="true"/>
            <li data-search-path="library" data-search-heading="All Documents">↪ <a href="/">D.C. Law Library</a></li>
            <li data-search-path="library|dclaws" data-search-heading="D.C. Laws">↪ <a href="/dclaws/">D.C. Laws Codified in the D.C. Code</a></li>
            <li data-search-path="library|dclaws|23" data-search-heading="">↪ <a href="/dclaws/23/">Council Period 23 (2019-2020)</a></li>
            <li data-search-path="library|dclaws|23|permanent" data-search-heading="">↪ <a href="/dclaws/23/permanent/">Permanent Laws</a></li>
            <li data-search-path="library|dclaws|23|permanent|pending" data-search-heading="">↪ <a href="/dclaws/23/permanent/pending/">Acts pending congressional review</a></li>
            <li data-search-path="library|dclaws|23|permanent|pending|D.C. Act 23-536" data-search-heading="D.C. Act 23-536">↪ D.C. Act 23-536. Opioid Overdose Treatment and Prevention Omnibus Amendment Act of 2020.</li>
          </ul>
          <div class="document-info">
            <h2>Law Information</h2>
            <dl>
              <dt>Cites</dt>
              <dd>D.C. Act 23-536 (<a class="internal-link" href="https://lims.dccouncil.us/downloads/LIMS/41645/Signed_Act/B23-0054-Signed_Act.pdf">PDF</a>)<br/>68 DCR 00008<br/></dd>
              <dt>Effective</dt>
              <dd>Mar. 19, 2021 (Projected)</dd>
              <dt>Legislative History (<a href="https://lims.dccouncil.us/Legislation/B23-0054">LIMS</a>)</dt>
            </dl>
          </div>
          <section class="cta">
            <p>
              <a href="mailto:code@dccouncil.us?subject=[ERROR]+/dc/council/acts/23-536.html">Report Error</a>
            </p>
            <p>
              <a href="mailto:code@dccouncil.us?subject=[FEEDBACK]+/dc/council/acts/23-536.html">Website Feedback</a>
            </p>
            <p>We cannot respond to questions regarding the law.</p>
          </section>
        </aside>
        <section class="col8 body">
          <section class="pending_notice">
        This act is <strong>not yet codified</strong> in the D.C. Code because it is not yet effective as law. It is projected to become effective on Mar. 19, 2021.
      </section>
          <h1 id="/dc/council/acts/23-536.html">D.C. Act 23-536. Opioid Overdose Treatment and Prevention Omnibus Amendment Act of 2020.</h1>
          <section class="content">
            <p style="text-align: center;">AN ACT</p>
            <p style="font-style: italic">To amend An Act To relieve physicians of liability for negligent medical treatment at the scene of an accident in the District of Columbia to expand the District's Good Samaritan law to decriminalize certain offenses, in the event of an overdose, for individuals who administer opioid antagonists, those on whom opioid antagonists are administered, and bystanders, and to permit a court to consider, as a mitigating factor in criminal prosecutions and sentencing, the administration of an opioid antagonist; to amend the Opioid Overdose Treatment and Prevention Omnibus Act of 2018 to require the Metropolitan Police Department and Department of Health to provide opioid antagonist rescue kits to certain District government employees, issue guidance, and report relevant data, and to provide certain civil and criminal immunity from liability for the distribution and administration of opioid antagonists by those employees; to amend the District of Columbia Uniform Controlled Substances Act of 1981 to decriminalize the possession of injection-related drug paraphernalia; and to amend the Drug Paraphernalia Act of 1982 to decriminalize certain activities relating to drug paraphernalia for personal use of a controlled substance.</p>
            <p>BE IT ENACTED BY THE COUNCIL OF THE DISTRICT OF COLUMBIA, That this act may be cited as the "Opioid Overdose Treatment and Prevention Omnibus Amendment Act of 2020".</p>
            <p id="&#xA7;2"><span class="level-num">Sec. 2. </span>Section 3 of An Act To relieve physicians of liability for negligent medical treatment at the scene of an accident in the District of Columbia, effective March 19, 2013 (D.C. Law 19-243; D.C. Official Code § 7-403), is amended as follows:</p>
            <p class="text-indent-1"><span class="level-num" id="&#xA7;2(a)">(a)</span> Subsection (a)(1) is amended as follows:</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(a)(1)">(1)</span> Subparagraph (A) is amended by striking the phrase "for himself or herself" and inserting the phrase "for or administers an opioid antagonist to himself or herself" in its place.</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(a)(2)">(2)</span> Subparagraph (B) is amended by striking the phrase "for that person; or" and inserting the phrase "for or administers an opioid antagonist to that person;" in its place.</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(a)(3)">(3)</span> Subparagraph (C) is amended by striking the phrase "is sought; and" and inserting the phrase "is sought or to whom an opioid antagonist is administered; or" in its place.</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(a)(4)">(4)</span> A new subparagraph (D) is added to read as follows:</p>
            <p class="text-indent-3">"<span class="level-num" id="">(D)</span> Is a bystander to a situation described in subparagraph (A), (B), or (C) of this paragraph; and".</p>
            <p class="text-indent-1"><span class="level-num" id="&#xA7;2(b)">(b)</span> Subsection (b)(3) is repealed.</p>
            <p class="text-indent-1"><span class="level-num" id="&#xA7;2(c)">(c)</span> Subsection (c) is amended to read as follows:</p>
            <p class="text-indent-1">"<span class="level-num" id="">(c)</span> The seeking of health care or administration of an opioid antagonist under subsection (a) of this section, whether or not presented by the parties, may be considered by the court as a mitigating factor in any criminal prosecution or sentencing for an offense that is not listed in subsection (b) of this section.".</p>
            <p id="&#xA7;3"><span class="level-num">Sec. 3. </span>The Opioid Overdose Treatment and Prevention Omnibus Act of 2018, effective April 11, 2019 (D.C. Law 22-288; D.C. Official Code § 7-3201 <em>et seq.</em>), is amended as follows:</p>
            <p class="text-indent-1"><span class="level-num" id="&#xA7;3(a)">(a)</span> Section 101 (D.C. Official Code § 7-3201) is amended by adding new paragraphs (9A), (9B), and (9C) to read as follows:</p>
            <p class="text-indent-2">"<span class="level-num" id="">(9A)</span> "MPD" means the Metropolitan Police Department.</p>
            <p class="text-indent-2">"<span class="level-num" id="">(9B)</span> "Opioid antagonist" shall have the same meaning as provided in section 3(i)(2) of An Act To relieve physicians of liability for negligent medical treatment at the scene of an accident in the District of Columbia, effective March 19, 2013 (D.C. Law 19-243; D.C. Official Code § 7-403(i)(2)).</p>
            <p class="text-indent-2">"<span class="level-num" id="">(9C)</span> "Opioid antagonist rescue kit" means a kit that contains:</p>
            <p class="text-indent-3">"<span class="level-num" id="">(A)</span> An opioid antagonist;</p>
            <p class="text-indent-3">"<span class="level-num" id="">(B)</span> Overdose educational materials that:</p>
            <p class="text-indent-4">"<span class="level-num" id="">(i)</span> Conform to DOH or federal Substance Abuse and Mental Health Services Administration guidelines for opioid overdose education;</p>
            <p class="text-indent-4">"<span class="level-num" id="">(ii)</span> Explain the signs and causes of an opioid overdose; and</p>
            <p class="text-indent-4">"<span class="level-num" id="">(iii)</span> Instruct individuals when and how to administer an opioid antagonist in accordance with best medical practices; and</p>
            <p class="text-indent-3">"<span class="level-num" id="">(C)</span> Up-to-date information on how and where to access opioid use disorder treatment in the District.".</p>
            <p class="text-indent-1"><span class="level-num" id="&#xA7;3(b)">(b)</span> A new section 104a is added to read as follows:</p>
            <p id="">"<span class="level-num">Sec. 104a. </span>District government use of opioid antagonists.</p>
            <p class="text-indent-1">"<span class="level-num" id="">(a)</span> MPD shall:</p>
            <p class="text-indent-2">"<span class="level-num" id="">(1)</span> Provide opioid antagonist rescue kits to all its sworn personnel;</p>
            <p class="text-indent-2">"<span class="level-num" id="">(2)</span> Require sworn personnel to carry opioid antagonist rescue kits and administer opioid antagonists in accordance with MPD's written directives; and</p>
            <p class="text-indent-2">"<span class="level-num" id="">(3)</span> Report monthly data regarding the administration of opioid antagonists by its sworn personnel to the Chairpersons of the Council committees with jurisdiction over health and judiciary and public safety matters, including the:</p>
            <p class="text-indent-3">"<span class="level-num" id="">(A)</span> Number of individuals to whom an opioid antagonist was administered;</p>
            <p class="text-indent-3">"<span class="level-num" id="">(B)</span> Police districts in which those opioid antagonists were administered; and</p>
            <p class="text-indent-3">"<span class="level-num" id="">(C)</span> Number of opioid antagonists administered.</p>
            <p class="text-indent-1">"<span class="level-num" id="">(b)</span> DOH shall:</p>
            <p class="text-indent-2">"<span class="level-num" id="">(1)</span> Make opioid antagonist rescue kits available, as needed, to District agencies under the purview of the Deputy Mayor for Health and Human Services, including the Child and Family Services Agency, DBH, and the Department of Human Services;</p>
            <p class="text-indent-2">"<span class="level-num" id="">(2)</span> Establish policies and procedures governing the safe distribution and administration of opioid antagonists; and</p>
            <p class="text-indent-2">"<span class="level-num" id="">(3)</span> Report monthly data regarding the distribution and administration of opioid antagonists by non-MPD District agency personnel to the Chairpersons of the Council committees with jurisdiction over health and judiciary and public safety matters, including:</p>
            <p class="text-indent-3">"<span class="level-num" id="">(A)</span> The number of individuals to whom an opioid antagonist was administered;</p>
            <p class="text-indent-3">"<span class="level-num" id="">(B)</span> The wards in which those opioid antagonists were administered;</p>
            <p class="text-indent-3">"<span class="level-num" id="">(C)</span> The agencies whose personnel administered the opioid antagonists; and</p>
            <p class="text-indent-3">"<span class="level-num" id="">(D)</span> Any follow-up by the agencies provided to individuals to whom an opioid antagonist was administered, such as referrals for opioid use disorder treatment.</p>
            <p class="text-indent-1">"<span class="level-num" id="">(c)</span> A District government employee who distributes or administers an opioid antagonist in accordance with this section shall be immune from civil or criminal liability for that distribution or administration; except, that no immunity shall extend to recklessness, gross negligence, intentional misconduct, or a willful or wanton disregard for the health or safety of others.</p>
            <p class="text-indent-1">"<span class="level-num" id="">(d)</span> In developing any training for District employees related to this section, the District shall consult with individuals with lived experience of opioid use or opioid use disorder.".</p>
            <p id="&#xA7;4"><span class="level-num">Sec. 4. </span>Section 410 of the District of Columbia Uniform Controlled Substances Act of 1981, effective August 5, 1981 (D.C. Law 4-29; D.C. Official Code § 48-904.10), is repealed.</p>
            <p id="&#xA7;5"><span class="level-num">Sec. 5. </span>The Drug Paraphernalia Act of 1982, effective September 17, 1982 (D.C. Law 4-149; D.C. Official Code § 48-1101 <em>et seq.</em>), is amended as follows:</p>
            <p class="text-indent-1"><span class="level-num" id="&#xA7;5(a)">(a)</span> Section 2 (D.C. Official Code § 48-1101) is amended by adding a new paragraph (4) to read as follows:</p>
            <p class="text-indent-2">"<span class="level-num" id="">(4)</span> "Personal use" means use or possession in circumstances where there is insufficient evidence of intent to distribute or manufacture a controlled substance.".</p>
            <p class="text-indent-1"><span class="level-num" id="&#xA7;5(b)">(b)</span> Section 4 (D.C. Official Code § 48-1103) is amended as follows:</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;5(b)(1)">(1)</span> Subsection (a)(1A) is amended to read as follows:</p>
            <p class="text-indent-2">"<span class="level-num" id="">(1A)</span> Notwithstanding paragraph (1) of this subsection, it shall not be unlawful for a person to use, or possess with the intent to use, drug paraphernalia for the personal use of a controlled substance.".</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;5(b)(2)">(2)</span> Subsection (b)(1A) is amended by striking the phrase "the materials described in section 2(3)(D)" and inserting the phrase "drug paraphernalia for the personal use of a controlled substance" in its place.</p>
            <p class="text-indent-1"><span class="level-num" id="&#xA7;5(c)">(c)</span> Section 4a(d) (D.C. Official Code § 48-1103.01(d)) is amended by striking the phrase "act or section 410 of the District of Columbia Uniformed Controlled Substances Act of 1981, effective August 5, 1981 (D.C. Law 4-29; D.C. Code § 33-550)" and inserting the word "act" in its place.</p>
            <p class="text-indent-1"><span class="level-num" id="&#xA7;5(d)">(d)</span> Section 5(b) (D.C. Official Code § 48-1104(b)) is repealed.</p>
            <p id="&#xA7;6"><span class="level-num">Sec. 6. </span>Applicability.</p>
            <p class="text-indent-1"><span class="level-num" id="&#xA7;6(a)">(a)</span> Section 3 of this act shall apply upon the date of inclusion of its fiscal effect in an approved budget and financial plan.</p>
            <p class="text-indent-1"><span class="level-num" id="&#xA7;6(b)">(b)</span> The Chief Financial Officer shall certify the date of the inclusion of the fiscal effect in an approved budget and financial plan, and provide notice to the Budget Director of the Council of the certification.</p>
            <p class="text-indent-1"><span class="level-num" id="&#xA7;6(c)">(c)</span><span class="level-num" id="&#xA7;6(c)(1)">(1)</span> The Budget Director shall cause the notice of the certification to be published in the District of Columbia Register.</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;6(c)(2)">(2)</span> The date of publication of the notice of the certification shall not affect the applicability of the provision identified in subsection (a) of this section.</p>
            <p id="&#xA7;7"><span class="level-num">Sec. 7. </span>Fiscal impact statement.</p>
            <p>The Council adopts the fiscal impact statement in the committee report as the fiscal impact statement required by section 4a of the General Legislative Procedures Act of 1975, approved October 16, 2006 (120 Stat. 2038; D.C. Official Code § 1-301.47a).</p>
            <p id="&#xA7;8"><span class="level-num">Sec. 8. </span>Effective date.</p>
            <p>This act shall take effect following approval by the Mayor (or in the event of veto by the Mayor, action by the Council to override the veto), a 30-day period of congressional review as provided in section 602(c)(1) of the District of Columbia Home Rule Act, approved December 24, 1973 (87 Stat. 813; D.C. Official Code § 1-206.02(c)(1)), and publication in the District of Columbia Register.</p>
          </section>
        </section>
      </div>
    </main>
    <footer>
      <section class="container center">
        <p>The codes and laws on this website are in the public domain.</p>
        <p>
              Please do not scrape. Instead, bulk download the <a href="https://github.com/dccouncil/dc-law-html">HTML</a> or <a href="https://github.com/dccouncil/dc-law-xml">XML</a>.
            </p>
        <p>Powered by the non-profit <a href="http://www.openlawlib.org/">Open Law Library</a>.</p>
      </section>
    </footer>
    <script type="text/javascript" src="/js/main.js"> </script>
  </body>
</html>
